When Jodie Ofosuhene learned she had breast cancer at age 29 in 2016, she got more than standard medical care. She was connected with Noel Peters, a former patient who serves as a mentor to new ones. “Noel helped me tremendously,” Ms.

There's a lot of questions doing the rounds on forums and messages about the approval of Lutathera (PRRT) in USA, Europe and other places. This is not a place just for one particular country, I want a place to review what is happening globally…

Health care professionals worldwide are increasingly leveraging the power of social media to speak directly with their respective communities, teach and share knowledge. They've taken to Twitter to share their experiences and opinions on a myriad…

I've made no secret of the fact that I don't believe Neuroendocrine Cancer is rare and you can read why in some detail in my article Neuroendocrine Cancer – not as rare as you think. Better diagnostic technology, greater awareness and better…

The FDA granted an accelerated approval to the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) for the treatment of adult and pediatric patients 12 years and older with microsatellite instability-high (MSI-H) or mismatch repair deficient…

I've never used the reblog button until now ………… this is such a powerful post, so I wanted those following me on WordPress or email, and are not on Facebook, to have the opportunity to read it. Hey Guys, I'm also active…

The Sydney Morning Herald – Jul 11, 2018, 12:51 AM

Australian shoppers would see a confronting 16 teaspoons of sugar on the label of a 600-millilitre Coca-Cola bottle if the federal government adopted one of the more contentious options in its new sugar-labelling paper. The federal government has…

Cancer is a growth industry (literally!). More people are being diagnosed than ever before. Fortunately, more people are surviving than ever before. This is against a backdrop of better awareness, better screening in the big population cancers, and…

According to recent surveys, approximately 70% of the U.S. population use social media to connect with one another, engage with news content, and share information. At the ASCO annual meeting last month, MedPage Today caught up with two oncologists…

Eight years ago today, I was sat in front of a secondary care consultant, his speciality was colorectal. I asked specifically for this consultant for two reasons, firstly, he carried out a colonoscopy some 20 months previously which turned out to…